研报掘金丨国海证券:维持万华化学“买入”评级,经营彰显韧性,长期成长可期

格隆汇
Aug 13

国海证券研报指出,万华化学2025H1受产品价差收缩影响,业绩有所下滑。子公司经营方面,2025H1匈牙利BC公司亏损0.9亿元,较2024年下半年大幅减亏。公司作为全球聚氨酯龙头企业,规模优势显著。聚氨酯板块:万华福建MDI将技改扩能新增70万吨/年,预计2026Q2完成;万华福建第二套33万吨/年TDI项目预计2025年建成投产。石化板块:2024年,万华蓬莱一期PDH等项目完成建设并实现一次性开车成功。2025年初,万华烟台25万吨/年LDPE装置一次性开车成功,2025年4月3日,万华化学烟台产业园乙烯二期120万吨/年乙烯装置一次开车成功,乙烯一期项目进行乙烷进料改造。精细化学品及新材料板块:ADI业务深化全球布局;MS树脂装置一次性开车成功,成功填补国内高端光学级MS规模化生产空白;维生素A全产业链贯通。公司是聚氨酯行业龙头,规模优势显著,维持“买入”评级。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10